16:30
#75 EFFICACY AND SAFETY OF INTRAVESICAL ONABOTULIUMTOXIN A INJECTION ON PATIENTS WITH IDIOPATHIC DETRUSOR OVERACTIVITY AND DIABETES MELLITUS
Presenter: Chung-Cheng Wang
Wang C1, Kuo H21. Department of Urology, En Chu Kong Hospital, New Taipei City, Taiwan, 2. Department of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University, Hualien, Taiwan
16:35
#76 Urine Culture Changed after Botulinum Toxin A Detrusor Injections in 26 Patients with Neurogenic Detrusor Overactivity caused by Spinal Cord Injury: A Single-center Longitudinal Perspective Study
Presenter: Chunsong Jia
Jia C1, Liao L11. Department of Urology, China Rehabilitation Research Center, School of Rehabilitation Medicine, Capital Medical University, Beijing 100068; China
16:40
#77 DIFFERENCE OF THE THERAPEUTIC EFFECT BETWEEN REPEATED DETRUSOR INJECTIONS OF 200 U AND 300 U BOTULINUM TOXIN A ON GLOMERULAR FILTRATION RATE IN CHRONIC SPINAL CORD INJURED PATIENTS
Presenter: Yi-Chou Chen
Chen Y1, Wang C2, Kuo H31. Department of Urology, Hualien General Hospital, Hualien, Taiwan, 2. Department of Urology, En Chu Kong Hospital, New Taipei City, Taiwan, 3. Department of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University, Hualien, Taiwan
16:45
#78 Detrusorial injections of Botulinum Toxin in multiple sclerosis: long-term experience of a single centre
Presenter: Elena Andretta
Andretta E1, Zuliani C2, Fattorello C2, Artuso G11. Department of Urology – General Hospital DOLO (Venice), 2. Department of Neurology – General Hospital MIRANO (Venice)
16:50
#79 UNILATERAL VERSUS BILATERAL TINED LEAD STIMULATION IN PATIENT’S SELECTION FOR SACRAL NERVE STIMULATION
Presenter: Le Mai Tu
Richard P1, Tu L M21. Université de Sherbrooke, 2. Centre Hospitalier Universitaire de Sherbrooke (CHUS),Sherbrooke,Canada
16:55
#80 "Conventional" peripheral nerve evaluation test vs. "Two-stage-implantation" - comparison of response rates in sacral nerve stimulation
Presenter: Andreas Bannowsky
Bannowsky A1, Sugimoto S2, Böhler G3, van Ahlen R1, van Ahlen H1, Jünemann K31. Klinikum Osnabrück, Dept. of urology, 2. University Hospital Tokyo, Dept. of urology, 3. University Hospital Schleswig-Holstein, Campus Kiel, Germany
17:00
#81 Sacral neuromodulation in patients with idiopathic overactive bladder after initial botulinum toxin therapy.
Presenter: Martijn Smits
Smits M1, de Wachter S11. Maastricht University Medical Centre
17:05
#82 IS LONG-TERM FOLLOW-UP REQUIRED FOR ADULT MYELOMENINGOCELE PATIENTS AFTER LOWER URINARY TRACT RECONSTRUCTIVE SURGERY?
Presenter: Michael Vainrib
Vainrib M1, Ginsberg D A11. University of Southern California
17:10
#83 Long-term outcome of augmentation ileocystoplasty in patients with neurogenic lower urinary tract dysfunction
Presenter: Barbara Hermans
Hermans B1, De Ridder D1, Van der Aa F11. University Hospitals Leuven
17:15
#84 Risk factors predict upper urinary tract deterioration in patients with spinal cord injury--a longitudinal study
Presenter: Zhihua Zhang
Zhang Z1, Liao L21. Department of Urology, China Rehabilitation Research Center, School of Rehabilitation Medicine, Capital Medical University, Beijing 100068; China. Second Affiliated Hospital Zhejiang University College Of Medicine,Hangzhou310000;China, 2. Department of Urology, China Rehabilitation Research Center, School of Rehabilitation Medicine, Capital Medical University, Beijing 100068; China
17:20
#85 Clean intermittent catheterization is a challenge in patients suffering from multiple sclerosis: our experience with 115 patients.
Presenter: Veronique Keppenne
Keppenne V1, Bottin C2, Dive D2, Waltregny D21. CHU Liege, 2. CHU Liege
17:25
#86 Prevalence of Stress Urinary Incontinence in Women with Multiple Sclerosis
Presenter: Howard Goldman
Murphy A1, Bethoux F1, Stough D1, Goldman H11. Cleveland Clinic